Blog
RSS FeedPosted by Michael Wonder on 02 Jul 2026
‘Lifesaver’ opioid disorder treatment pulled from Australia
1 July 2026 - Sublocade, used to treat people with opioid use disorder, will be removed from the PBS and all ...
Posted by Michael Wonder on 02 Jul 2026
Stoush over ‘archaic pricing’ threatens access to key drugs
1 July 2026 - Thousands of patients with multiple sclerosis face the prospect of losing publicly funded access to vital ...
Posted by Michael Wonder on 30 Jun 2026
Schedule of Pharmaceutical Benefits - 1 July 2026
1 July 2026 - The July 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Jun 2026
PBS cost recovery fees and charges 2026-2027
30 June 2026 - Cost Recovery involves the Australian Government charging the non-government sector for some or all of the efficient ...
Posted by Michael Wonder on 30 Jun 2026
Bumper month for cheaper medicines with 10 new PBS listings for July
29 June 2026 - July is a bumper month for cheaper medicines with 10 new listings giving Australians expanded access ...
Posted by Michael Wonder on 28 Jun 2026
Health Minister: our PBS is a world leading scheme but it can be better
27 June 2026 - In Australia, access to high-quality, innovative and affordable medicines isn’t just a nice-to-have, it’s fundamental to ...
Posted by Michael Wonder on 26 Jun 2026
New-gen medicines are available for migraine and arthritis – but only if you fail the old drugs
25 June 2026 - Australia’s drug approvals processes act as a “rationing system” that forces people to fail treatment on ...
Posted by Michael Wonder on 23 Jun 2026
Principles of broad (multi-cancer) listings for programmed cell death-1/programmed death ligand-1 (PD-(L)1) inhibitors
23 June 2026 - The Department has published a fact sheet ‘Principles for broad (multi-cancer) listings for programmed cell death-1/programmed ...
Posted by Michael Wonder on 23 Jun 2026
When big pharma clashes with public policy, people such as Aimee pay the price
23 June 2026 - Mother of two and cancer patient Aimee Glen says the decision by a pharmaceutical giant to remove ...
Posted by Michael Wonder on 23 Jun 2026
Affording the successes of science
20 June 2026 - Australia needs a difficult conversation about the world’s best medicines, what they cost and who should pay. ...
Posted by Michael Wonder on 22 Jun 2026
They’re on the PBS but Xavier still can’t access these cancer drugs
20 June 2026 - The eight-year-old and his family will travel to America next month to pick up medicine that is ...
Posted by Michael Wonder on 22 Jun 2026
Australia’s drug approval system faces reckoning as patients await reform
22 June 2026 - Health Minister Mark Butler has tied long-overdue drug pricing reforms to July negotiations with pharma, leaving Australia’s ...
Posted by Michael Wonder on 20 Jun 2026
Mounjaro rejection explains why our access to cheaper medicines if failing
20 June 2026 - The rejection by one of the world’s biggest pharmaceutical companies of Australia’s proferred bargain over the ...
Posted by Michael Wonder on 20 Jun 2026
Australian patients risk losing lifesaving medicines amid pharmaceutical subsidy crisis
20 June 2026 - Australian patients risk losing access to lifesaving medicines, with the nation “cleaved off” from global drug ...
Posted by Michael Wonder on 19 Jun 2026
Recommendations made by the PBAC – May 2026
19 June 2026 - Recommendations made by the PBAC in May 2026 relating to the listing of medicines on the PBS ...